trending Market Intelligence /marketintelligence/en/news-insights/trending/xdojehchnbff0pahyvg6va2 content esgSubNav
In This List

Pieris Pharmaceuticals closes common stock offering

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Pieris Pharmaceuticals closes common stock offering

Pieris Pharmaceuticals Inc. closed its underwritten public offering of 6,325,000 common shares at $8 apiece with gross proceeds of about $50.6 million.

The shares sold include the full exercise of the underwriters' option to buy up to an additional 825,000 common shares.

The Boston-based drugmaker plans to use the proceeds for working capital and general corporate purposes, including advancing the development of its drug candidates.

Jefferies, Cowen and Evercore ISI acted as joint book-running managers for the offering.